Medication Adherence
Conditions
Keywords
schizophrenia, medication adherence, smartphone app, psychiatric symptoms
Brief summary
This is an experimental study which aims to explore the effectiveness of a smartphone app for medication adherence (MedAdhere app) among schizophrenic patients for eight weeks.
Detailed description
Schizophrenia is a mental disorder that causes severe functional disabilities and imposes a heavy economic burden. Poor medication adherence is one of the major causes of relapse of psychiatric symptoms in schizophrenic patients. This is an experimental study which aims to explore the effectiveness of a smartphone app for medication adherence (MedAdhere app) among schizophrenic patients for eight weeks.
Interventions
BEHAVIORALthe MedAdhere app
The experimental group downloaded and used the MedAdhere app on their personal smartphones during this 8-week study
Sponsors
Kaohsiung Medical University Chung-Ho Memorial Hospital
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* schizophrenia * aged 20 to 65 years * able to read traditional Chinese * owning a smartphone * currently admitted at a psychiatric day-care center
Exclusion criteria
* Intellectually disabled or severe cognitive function impairment (Dementia)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| psychiatric symptoms | Change from Baseline psychiatric symptoms at 8 weeks | The positive and negative syndrome scale was used to measure participants' psychiatric symptoms. Of the 30 items on the scale, seven are positive symptoms, seven are negative symptoms, and 16 are general psychopathology symptoms. Symptom severity for each item is rated according to the anchoring points in the 7-point scale (1 = absent; 7 = extreme) that best describe the symptom (Kay et al., 1987). The PANSS score is the sum of ratings across items, ranging from 7 to 49 for the Positive, Negative Scales, and 16 to 112 and 16 to 112 for the General Psychopathology Scale. |
| cognitive functions | Change from Baseline cognitive functions at 8 weeks | The Mini-Mental State Examination was used to measure participants' cognitive functions. The MMSE consists of 15 questions for assessing the following seven cognitive domains: orientation in time and place, memory registration and recall, attention and calculation, and language. The total MMSE score ranged from 0 to 30, and higher scores indicate better cognitive functions. |
| Medication adherence rate | Change from Baseline Medication adherence' rate at 8 weeks | Utilizing cloud-based platforms to compute the medication adherence rate. |
Countries
Taiwan
Outcome results
None listed